Clinical Trial Update: Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial registry entry describes evaluating the glycemic control and weight loss effects of a GLP-1 receptor agonist in people with spinal c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury
• Type 2 Diabetes Mellitus

Drugs mentioned

• GLP-1 receptor agonist

Snippet

Sponsor: Marzieh Salehi | Conditions: Spinal Cord Injuries, Type 2 Diabetes | Phase 4 | Status: RECRUITING